Placeholder Banner

Announcing BUZZ of BIO Winners for the 2017 BIO CEO & Investor Conference

December 14, 2016
BIO is pleased to announce the winners of the Buzz of BIO contest for the 2017 BIO CEO & Investor Conference, which recognizes highly innovative companies in the biotech sector looking to take their product to the next phase. Numerous pioneering biotech companies were nominated in each of three categories: Public Therapeutic Biotech, Private Therapeutic Biotech, and our newest category, Diagnostics and Beyond; voting closed December 12, 2016.


Agile Therapeutics, Inc. won in the Public Therapeutic Biotech category. Agile Therapeutics is a women’s health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products. Learn more about Agile Therapeutics, Inc.


Centrexion Therapeutics won in the Private Therapeutic Biotech category. Centrexion is focused on developing new therapies for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm. Learn more about Centrexion Therapeutics.

oncocyte-logo-428bOncoCyte Corporation won in our newest category, Diagnostics and Beyond. OncoCyte is focused on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. Learn more about OncoCyte Corporation.

Congratulations to all three companies! Each winner will receive complimentary conference registration, a company presentation in the corresponding track, and opportunities for promotion to industry leaders and investors including a spotlight in BioCentury Extra!

The 19th Annual BIO CEO & Investor Conference will take place February 13-14 at The Waldorf Astoria hotel in New York, NY, and as one of the largest investor conferences, it will focus on established and emerging publicly traded and select private biotech companies. Register before December 15 and receive our early bird discount!

Complimentary media registration is now available for qualified reporters working full time for print, broadcast, and web publications with valid press credentials.

Visit our website to learn more about the BIO CEO & Investor Conference, including registration, programming, company presentations, and partnering information.